Integra Lifesciences Holdings Corp IART
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IART is a good fit for your portfolio.
News
-
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
-
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
-
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
-
Integra LifeSciences Announces Leadership Transition Plan
-
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
-
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Investors to Contact the Firm
Trading Information
- Previous Close Price
- $29.36
- Day Range
- $27.21–29.38
- 52-Week Range
- $27.21–59.02
- Bid/Ask
- $28.48 / $28.52
- Market Cap
- $2.24 Bil
- Volume/Avg
- 1.1 Mil / 782,872
Key Statistics
- Price/Earnings (Normalized)
- 9.48
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 11.91%
Company Profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,946
- Website
- https://www.integralife.com
Comparables
Valuation
|
Metric
|
IART
|
CNMD
|
ZIMV
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.48 | 20.29 | 9.69 |
Price/Book Value | 1.45 | 2.58 | 1.05 |
Price/Sales | 1.53 | 1.77 | 0.91 |
Price/Cash Flow | 10.65 | 13.39 | 12.29 |
Price/Earnings
IART
CNMD
ZIMV
Financial Strength
|
Metric
|
IART
|
CNMD
|
ZIMV
|
|---|---|---|---|
Quick Ratio | 1.85 | 0.86 | 0.84 |
Current Ratio | 3.45 | 1.98 | 2.78 |
Interest Coverage | 2.24 | 3.03 | −1.51 |
Quick Ratio
IART
CNMD
ZIMV
Profitability
|
Metric
|
IART
|
CNMD
|
ZIMV
|
|---|---|---|---|
Return on Assets (Normalized) | 6.54% | 4.68% | 14.12% |
Return on Equity (Normalized) | 14.87% | 13.85% | 31.63% |
Return on Invested Capital (Normalized) | 8.36% | 7.73% | 18.79% |
Return on Assets
IART
CNMD
ZIMV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Yzhdplfnz | Gbjmyg | $185.5 Bil | |
SYK
| Stryker Corp | Wbvkfmcf | Jrpct | $128.2 Bil | |
MDT
| Medtronic PLC | Brhvmhxl | Jtjtfx | $106.7 Bil | |
BSX
| Boston Scientific Corp | Yhxjdlwym | Nrnjytx | $99.0 Bil | |
DXCM
| DexCom Inc | Bynnqtddq | Hqt | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Djlvpwrkj | Vswdpj | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Sdxndmxd | Yrdc | $24.9 Bil | |
ALGN
| Align Technology Inc | Dltrgsb | Whxvs | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Qzdhwnnh | Cbhcvl | $18.9 Bil | |
PODD
| Insulet Corp | Xdkxnggtw | Gydddhr | $11.7 Bil |